title: Pharmacotherapy and pregnancy: highlights from the Third International Conference for Individualized Pharmacotherapy in Pregnancy.
abstract: To address provider struggles to provide evidence-based, rational drug therapy to pregnant women, this third Conference was convened to highlight the current progress and research in the field. Speakers from academic centers, industry, and governmental institutions spoke about: the Food and Drug Administration's role in pregnancy pharmacology and the new labeling initiative; drug registries in pregnancy; the pharmacist's role in medication use in pregnancy; therapeutic areas such as preterm labor, gestational diabetes, nausea and vomiting in pregnancy, and hypertension; breast-feeding and medications; ethical challenges for consent in pregnancy drug studies; the potential for cord blood banks; and concerns about the fetus when studying drugs in pregnancy. The Conference highlighted several areas of collaboration within the current Obstetrics Pharmacology Research Units Network and hoped to educate providers, researchers, and agencies with the common goal to improve the ability to safely and effectively use individualized pharmacotherapy in pregnancy.
authors.affiliation: Indiana University School of Medicine, Indianapolis, IN, USA. dahaas@iupui.edu
authors.forename: David M
authors.initials: DM
authors.lastname: Haas
authors.forename: Beverly
authors.initials: B
authors.lastname: Gallauresi
authors.forename: Kristine
authors.initials: K
authors.lastname: Shields
authors.forename: Deborah
authors.initials: D
authors.lastname: Zeitlin
authors.forename: Shannon M
authors.initials: SM
authors.lastname: Clark
authors.forename: Mary F
authors.initials: MF
authors.lastname: Hebert
authors.forename: Zhaoxia
authors.initials: Z
authors.lastname: Ren
authors.forename: Srikanth C
authors.initials: SC
authors.lastname: Nallani
authors.forename: Eric M
authors.initials: EM
authors.lastname: Meslin
authors.forename: Karen B
authors.initials: KB
authors.lastname: Feibus
authors.forename: Gideon
authors.initials: G
authors.lastname: Koren
authors.forename: W Scott
authors.initials: WS
authors.lastname: Goebel
authors.forename: Thomas
authors.initials: T
authors.lastname: Easterling
authors.forename: Scott C
authors.initials: SC
authors.lastname: Denne
authors.forename: David A
authors.initials: DA
authors.lastname: Flockhart
authors.forename: Jamie L
authors.initials: JL
authors.lastname: Renbarger
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D001942:Breast Feeding; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007231:Infant, Newborn; D009316:National Institutes of Health (U.S.); D009325:Nausea / Q000150:complications / Q000188:drug therapy; D009774:Obstetrics / Q000379:methods; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D012042:Registries; D014481:United States; D014486:United States Food and Drug Administration